Propofol Market Report 2025 (Global Edition)

Global Propofol Market Report 2025 Market Size Split by Product Type (Powder Propofol, Liquid Propofol), by Application (Procedural Sedation, General Anesthesia), by End User (Ambulatory Surgery Cente...

Propofol Market Report Description

We have various report editions of Propofol Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Competitive Landscape of the Propofol Market

The competitive landscape of the propofol market is characterized by robust rivalry among key players striving for market dominance. Companies focus on product innovation, strategic collaborations, and geographic expansion to gain a competitive edge. Pricing strategies and regulatory compliance also play crucial roles in market positioning and growth.

Top Companies Market Share in Propofol Industry: (In no particular order of Rank)

• Aspen
• Xian Libang
• SGPharma Pvt Ltd
• Pfizer Inc
• B. Braun Melsungen AG
• Fresenius Kabi AG
• Nhwa
• Teva Pharmaceutical Industries Ltd
• Baxter International Inc
• Bachem
• SI Group
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Propofol Market

Which Region Will Dominate the Propofol Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024 and accounted for around 40% of the global revenue due to several factors. Firstly, the region boasts advanced healthcare infrastructure and high healthcare expenditure, facilitating widespread adoption of propofol in surgical procedures. Additionally, a large geriatric population prone to chronic diseases necessitates frequent surgical interventions, thereby driving propofol sales. Moreover, the presence of established pharmaceutical companies and research institutions fosters innovation and product development, further propelling market growth. Regulatory frameworks ensuring quality standards and patient safety also contribute to the region's dominance in propofol sales.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is the fastest-growing region due to various factors. Rapid urbanization and economic development in countries like China and India have led to improved healthcare infrastructure and increased access to surgical procedures, boosting demand for propofol. Additionally, rising healthcare expenditure and growing awareness about advanced medical treatments among the populace fuel market expansion. Furthermore, the prevalence of chronic diseases and an aging population in the region drive the need for surgical interventions, further propelling propofol sales. Moreover, favourable government initiatives and increasing investments in healthcare infrastructure contribute to the region's rapid market growth.

The current report Scope analyzes Propofol Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Propofol Market

According to Cognitive Market Research, the global propofol market size was estimated at USD 1352.2 Million out of which North America held the major market of around 40% of the global revenue with a market size of USD 540.88 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.0% from 2024 to 2031. In North America, the sales of propofol are anticipated to increase due to the growing prevalence of chronic diseases requiring surgical interventions. Additionally, advancements in healthcare infrastructure and technology enhance the efficiency of surgical procedures, driving the demand for propofol. Moreover, increasing healthcare expenditure and favourable reimbursement policies contribute to market growth. Ambulatory surgery centres’ rising popularity offers convenient settings for outpatient procedures, further boosting propofol sales. General anaesthesia, holding a prominent market share, is expected to grow due to its essential role in various surgeries across the region.

Country Analysis

• According to Cognitive Market Research, The United States propofol market had a market share of USD 426.75 million in 2024 and is projected to grow at a CAGR of 8.8% during the forecast period. Propofol sales in the U.S. are set to rise due to the increasing prevalence of surgical procedures, advancements in healthcare technology, rising healthcare expenditure, and the expanding popularity of ambulatory surgery centres.
• Canada propofol market had a market share of USD 64.91 million in 2024 and is projected to grow at a CAGR of 9.8% during the forecast period. In Canada, propofol sales will increase owing to the growing aging population, rising prevalence of chronic diseases, advancements in surgical techniques, and increased investments in healthcare infrastructure.
• Mexico propofol market had a market share of USD 49.22 million in 2024 and is projected to grow at a CAGR of 9.5% during the forecast period.

Europe Propofol Market

According to Cognitive Market Research, with a market value of USD 1352.2 million in 2024 out of which Europe held the major market of around 30% of the global revenue with a market size of USD 405.66 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.3% from 2024 to 2031. In Europe, the sales of propofol are poised to increase as healthcare systems invest in expanding surgical capacities to meet rising demand. Additionally, stringent regulatory standards ensure the quality and safety of propofol products, fostering consumer confidence and market growth. Furthermore, the prevalence of lifestyle-related diseases necessitates surgical interventions, driving propofol demand. Ambulatory surgery centres are gaining traction as preferred settings for outpatient procedures, contributing to propofol sales growth. Procedural sedation, the fastest-growing segment, is anticipated to thrive in Europe, catering to the increasing demand for minimally invasive treatments.

• The United Kingdom propofol market had a market share of USD 68.15 million in 2024 and is projected to grow at a CAGR of 10.1% during the forecast period. The UK will witness a surge in propofol sales due to the expanding healthcare infrastructure, rising demand for surgical interventions, stringent regulatory standards ensuring product quality, and increasing adoption of ambulatory surgery centres.
• France propofol market had a market share of USD 37.32 million in 2024 and is projected to grow at a CAGR of 8.5% during the forecast period.
• Germany propofol market had a market share of USD 80.32 million in 2024 and is projected to grow at a CAGR of 9.5% during the forecast period. Propofol sales in Germany are expected to increase due to advancements in medical technology, rising healthcare expenditure, increasing access to surgical procedures, and the growing prevalence of lifestyle-related diseases necessitating surgical interventions.
• Italy propofol market had a market share of USD 34.89 million in 2024 and is projected to grow at a CAGR of 8.7% during the forecast period.
• Russia propofol market had a market share of USD 62.88 million in 2024 and is projected to grow at a CAGR of 8.3% during the forecast period.
• Spain propofol market had a market share of USD 33.26 million in 2024 and is projected to grow at a CAGR of 8.4% during the forecast period.
• Luxembourg propofol market had a market share of USD 12.58 million in 2024 and is projected to grow at a CAGR of 9.4% during the forecast period.
• Portugal propofol market had a market share of USD 8.52 million in 2024 and is projected to grow at a CAGR of 9.1% during the forecast period.
• Greece propofol market had a market share of USD 4.87 million in 2024 and is projected to grow at a CAGR of 9.6% during the forecast period.
• Rest of Europe propofol market had a market share of USD 62.88 million in 2024 and is projected to grow at a CAGR of 8.0% during the forecast period.

 

Asia Pacific Propofol Market

According to Cognitive Market Research, the global propofol market size was estimated at USD 1352.2 Million out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 311.01 million in 2024 and will grow at a compound annual growth rate (CAGR) of 12.8% from 2024 to 2031. The sales of propofol in Asia Pacific are projected to surge due to expanding healthcare infrastructure and increasing access to surgical procedures. Moreover, the region's aging population and rising healthcare expenditure drive the demand for propofol in surgical interventions. Technological advancements in anaesthesia delivery systems enhance the efficiency and safety of propofol administration, further boosting sales. Ambulatory surgery centres are experiencing rapid growth, offering cost-effective and convenient options for outpatient procedures, thus fueling propofol demand. General anaesthesia, with its indispensable role in surgeries, is poised to grow as the highest market share segment in Asia Pacific.

• According to Cognitive Market Research, China propofol market had a market share of USD 139.95 million in 2024 and is projected to grow at a CAGR of 12.3% during the forecast period. In China, propofol sales will surge owing to the expanding healthcare infrastructure, rising disposable income, increasing healthcare expenditure, and government initiatives to improve healthcare accessibility and quality.
• Japan propofol market had a market share of USD 42.92 million in 2024 and is projected to grow at a CAGR of 11.3% during the forecast period.
• India propofol market had a market share of USD 37.32 million in 2024 and is projected to grow at a CAGR of 14.6% during the forecast period. Propofol sales in India will increase due to the growing population, rising prevalence of chronic diseases, advancements in healthcare technology, and increasing demand for surgical procedures across various medical specialties.
• South Korea propofol market had a market share of USD 31.10 million in 2024 and is projected to grow at a CAGR of 11.9% during the forecast period.
• Australia propofol market had a market share of USD 16.17 million in 2024 and is projected to grow at a CAGR of 12.5% during the forecast period.
• South East Asia propofol market had a market share of USD 21.46 million in 2024 and is projected to grow at a CAGR of 13.8% during the forecast period.
• Rest of Asia Pacific propofol market had a market share of USD 22.08 million in 2024 and is projected to grow at a CAGR of 12.6% during the forecast period.

South America Propofol Market

According to Cognitive Market Research, the global propofol market size was estimated at USD 1352.2 Million out of which Latin America market of around 5% of the global revenue with a market size of USD 67.61 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.2% from 2024 to 2031. In Latin America, the sales of propofol are expected to increase as healthcare systems invest in improving surgical capabilities and expanding access to medical services. Additionally, the region's growing population and rising prevalence of chronic diseases drive the demand for surgical interventions requiring propofol. Furthermore, advancements in anaesthesia techniques and equipment enhance the safety and efficacy of propofol administration, contributing to market growth. Ambulatory surgery centres are emerging as key providers of outpatient procedures, boosting propofol sales. Procedural sedation, with its ability to offer patient comfort during medical interventions, is anticipated to witness significant growth in Latin America.

• According to Cognitive Market Research, Brazil propofol market had a market share of USD 28.94 million in 2024 and is projected to grow at a CAGR of 10.8% during the forecast period. Brazil will witness a surge in propofol sales driven by the expanding healthcare sector, rising healthcare expenditure, increasing access to surgical interventions, and advancements in anaesthesia delivery systems ensuring patient safety and comfort.
• Argentina propofol market had a market share of USD 11.36 million in 2024 and is projected to grow at a CAGR of 11.1% during the forecast period. In Argentina, propofol sales will increase due to the rising prevalence of chronic diseases, expanding healthcare infrastructure, increasing adoption of advanced medical technologies, and the growing demand for surgical procedures.
• Colombia propofol market had a market share of USD 6.02 million in 2024 and is projected to grow at a CAGR of 10.0% during the forecast period.
• Peru propofol market had a market share of USD 5.54 million in 2024 and is projected to grow at a CAGR of 10.4% during the forecast period.
• Chile propofol market had a market share of USD 4.87 million in 2024 and is projected to grow at a CAGR of 10.5% during the forecast period.
• Rest of Latin America propofol market had a market share of USD 10.89 million in 2024 and is projected to grow at a CAGR of 9.3% during the forecast period.

 

Middle East Propofol Market

According to Cognitive Market Research, the global propofol market size was estimated at USD 1352.2 Million out of which Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 27.04 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.5% from 2024 to 2031. The sales of propofol in the Middle East and Africa (MEA) region are poised to increase due to expanding healthcare infrastructure and rising investments in medical services. Additionally, the region's growing population and increasing prevalence of chronic diseases drive the demand for surgical interventions requiring propofol. Furthermore, advancements in anaesthesia techniques and equipment enhance the safety and efficiency of propofol administration, contributing to market growth. Ambulatory surgery centres are gaining prominence as providers of outpatient procedures, thereby boosting propofol sales. General anaesthesia, being indispensable for various surgeries, is expected to maintain its position as the highest market share segment in MEA.

• According to Cognitive Market Research, GCC Countries propofol market had a market share of USD 11.57 million in 2024 and is projected to grow at a CAGR of 11.3% during the forecast period. Propofol sales in the GCC countries will surge due to the growing population, rising prevalence of lifestyle-related diseases, increasing investments in healthcare infrastructure, and government initiatives to enhance healthcare accessibility and quality.
• Egypt propofol market had a market share of USD 2.84 million in 2024 and is projected to grow at a CAGR of 10.8% during the forecast period.
• South Africa propofol market had a market share of USD 4.27 million in 2024 and is projected to grow at a CAGR of 11.5% during the forecast period. South Africa will witness a surge in propofol sales driven by the increasing prevalence of chronic diseases, advancements in healthcare technology, rising healthcare expenditure, and the expanding popularity of ambulatory surgery centres offering outpatient procedures.
• Turkey propofol market had a market share of USD 2.33 million in 2024 and is projected to grow at a CAGR of 10.0% during the forecast period.
• Nigeria propofol market had a market share of USD 2.84 million in 2024 and is projected to grow at a CAGR of 9.6% during the forecast period.
• Rest of MEA propofol market had a market share of USD 3.19 million in 2024 and is projected to grow at a CAGR of 9.5% during the forecast period.

Propofol Market Analysis

Propofol Product Type Segment Analysis

According to Cognitive Market Research, liquid propofol held the major market share over the forecast period due to its widespread usage in various surgical procedures. Its convenient formulation for intravenous administration and precise dosage control contribute to its popularity among healthcare providers. Moreover, the established efficacy and safety profile of liquid propofol further bolster its market share. Additionally, advancements in manufacturing processes and packaging technologies enhance the stability and shelf-life of liquid propofol, driving its continued sales growth.

Powder propofol is the fastest-growing category over the forecast period due to several factors. Its potential advantages, such as ease of storage, transportation, and potential for reconstitution, make it increasingly attractive for healthcare facilities. Moreover, the growing preference for powdered formulations among healthcare professionals seeking customizable dosage options and reduced wastage fuels market expansion. Additionally, advancements in powder formulation technologies and packaging solutions enhance the stability and convenience of powder propofol, further driving its adoption and sales growth.

• Powder Propofol
• Liquid Propofol

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Propofol Industry. Request a Free Sample PDF!

Propofol Application Segment Analysis

According to Cognitive Market Research, general anaesthesia hold a prominent market share due to its indispensable role in various surgical procedures requiring complete unconsciousness. The rising volume of surgeries worldwide, coupled with advancements in surgical techniques, drives the demand for general anaesthesia. Moreover, the efficacy of general anaesthesia in ensuring patient comfort and safety during surgeries further consolidates its market position. Additionally, advancements in anaesthesia delivery systems and monitoring devices enhance the efficiency and safety of general anaesthesia, contributing to increased sales.

Procedural sedation is the fastest-growing category over the forecast period owing to several factors. The increasing trend towards minimally invasive procedures and outpatient treatments necessitates effective sedation options. Procedural sedation offers patients comfort and relaxation during various medical procedures, driving its adoption. Moreover, advancements in sedation protocols and safety measures enhance the suitability of procedural sedation for a broader range of medical interventions, fuelling its market growth. Additionally, the rising demand for procedural sedation in emergency departments and ambulatory care settings further propels its sales expansion.

• Procedural Sedation
• General Anesthesia

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Propofol End User Segment Analysis

According to Cognitive Market Research, hospitals hold a prominent market share due to their role as primary healthcare providers and the high volume of surgical procedures performed therein. The increasing prevalence of chronic diseases necessitates frequent hospitalizations and surgical interventions, driving the demand for anaesthesia agents like propofol. Moreover, hospitals often possess advanced infrastructure and medical expertise, making them preferred settings for complex surgeries requiring anaesthesia. Additionally, the rising investments in hospital infrastructure and technology further bolster their capacity to cater to the growing demand for propofol.

Ambulatory surgery centres is the fastest-growing category over the forecast period due to several factors. The shift towards outpatient care and minimally invasive procedures drives the demand for ASCs, where patients receive timely and cost-effective surgical treatments. ASCs offer streamlined processes, shorter wait times, and reduced hospital stays, making them increasingly preferred for surgical interventions. Additionally, advancements in anaesthesia techniques and equipment enhance the safety and efficiency of procedures performed in ASCs, further fueling their growth. Moreover, favorable reimbursement policies and government initiatives promote the expansion of ASCs, driving the demand for propofol in these settings.

• Ambulatory Surgery Centers
• Hospitals
• Clinics
• Others

Propofol Distribution Channel Segment Analysis

• Online
• Offline

Propofol Packaging Segment Analysis

• Single use
• Multi-dose Vials

Author's Detail

Manoj Phagare

Senior Research Analyst at Cognitive Market Research

LinkedIn

Profile

• Worked on several market, industry & business research projects, on various models such as Syndicated, Custom, Subscriptions and Consults
• Proficient in secondary research and familiar with all paid research databases
• Proficient in primary research and handling client queries through mails and calls
• Expertise in statistical techniques used in data forecasting, possess strong grip on all aspects of market engineering & data analysis
• Expertise in checking feasibility of projects based on Request for Proposal (RFPs) of clients
• Acquainted with entire process of report writing- Title Analysis, TOC Building, Search Engine Optimization, TOC Freezing, Writing Reports, Market Engineering, Scheduling Primaries, Directory of Key Industry Participants (DKIP), Drafting “Press Articles/Summary/Report Description/Analyst Briefing” used for making marketing collaterals 
• Gained team-work skills in coordinating with the sales teams for business development and meeting needs of a variety of clients hand-in-hand with promoting sales.

Author's Conclusion